Mineralys Therapeutics, Inc.'s total assets for Q1 2024 were $347.25M, an increase of 38.00% from the previous quarter. MLYS total liabilities were $19.20M for the fiscal quarter, a 83.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.